CARCINOMA TRANSITIONAL CELL
Clinical trials for CARCINOMA TRANSITIONAL CELL explained in plain language.
Never miss a new study
Get alerted when new CARCINOMA TRANSITIONAL CELL trials appear
Sign up with your email to follow new studies for CARCINOMA TRANSITIONAL CELL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Experimental drug combo shows promise against tough bladder cancer
Disease control TerminatedThis study tested an experimental drug called enfortumab vedotin, alone or with other cancer treatments, in people with advanced or muscle-invasive bladder cancer. The goal was to see how safe the combinations were and whether they could shrink tumors. The study included 348 part…
Matched conditions: CARCINOMA TRANSITIONAL CELL
Phase: PHASE1, PHASE2 • Sponsor: Astellas Pharma Global Development, Inc. • Aim: Disease control
Last updated May 26, 2026 05:06 UTC
-
New bladder cancer treatment shows promise in early trial
Disease control TerminatedThis study tested a drug called enfortumab vedotin in 37 people with a type of bladder cancer that hasn't spread into the muscle wall. The drug was placed directly into the bladder using a thin tube. The main goals were to check for side effects and see if the drug could help tre…
Matched conditions: CARCINOMA TRANSITIONAL CELL
Phase: PHASE1 • Sponsor: Astellas Pharma Global Development, Inc. • Aim: Disease control
Last updated May 26, 2026 04:38 UTC